AIM
ARK Investment Management’s Beam Therapeutics BEAM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151M | Buy |
8,847,841
+367,752
| +4% | +$6.26M | 1.1% | 27 |
|
|
2025
Q1 | $166M | Buy |
8,480,089
+1,412,060
| +20% | +$27.6M | 1.66% | 19 |
|
|
2024
Q4 | $175M | Buy |
7,068,029
+536,930
| +8% | +$13.3M | 1.46% | 20 |
|
|
2024
Q3 | $160M | Sell |
6,531,099
-1,095,040
| -14% | -$26.8M | 1.46% | 21 |
|
|
2024
Q2 | $179M | Sell |
7,626,139
-556,035
| -7% | -$13M | 1.59% | 22 |
|
|
2024
Q1 | $270M | Sell |
8,182,174
-1,211,715
| -13% | -$40M | 1.87% | 15 |
|
|
2023
Q4 | $256M | Buy |
9,393,889
+609,998
| +7% | +$16.6M | 1.51% | 21 |
|
|
2023
Q3 | $211M | Buy |
8,783,891
+401,296
| +5% | +$9.65M | 1.62% | 20 |
|
|
2023
Q2 | $268M | Sell |
8,382,595
-190,834
| -2% | -$6.09M | 1.77% | 19 |
|
|
2023
Q1 | $263M | Buy |
8,573,429
+360,298
| +4% | +$11M | 1.8% | 19 |
|
|
2022
Q4 | $321M | Sell |
8,213,131
-277,805
| -3% | -$10.9M | 2.78% | 12 |
|
|
2022
Q3 | $405M | Sell |
8,490,936
-301,128
| -3% | -$14.3M | 2.82% | 12 |
|
|
2022
Q2 | $309M | Buy |
8,792,064
+591,315
| +7% | +$20.8M | 1.83% | 16 |
|
|
2022
Q1 | $470M | Buy |
8,200,749
+217,348
| +3% | +$12.5M | 1.96% | 15 |
|
|
2021
Q4 | $636M | Buy |
7,983,401
+1,141,679
| +17% | +$91M | 1.92% | 17 |
|
|
2021
Q3 | $595M | Buy |
6,841,722
+380,355
| +6% | +$33.1M | 1.43% | 21 |
|
|
2021
Q2 | $832M | Buy |
6,461,367
+1,682,263
| +35% | +$217M | 1.55% | 17 |
|
|
2021
Q1 | $383M | Buy |
4,779,104
+3,647,481
| +322% | +$292M | 0.76% | 40 |
|
|
2020
Q4 | $92.4M | Buy |
+1,131,623
| New | +$92.4M | 0.25% | 74 |
|